10/4/2026, 3:31:02 pm

Semaglutide generics gain on Mounjaro in March

Mounjaro sales dropped to ₹114 crore in March, the lowest since December, following the entry of semaglutide generics. Semaglutide sales rose to ₹59 crore despite a late-month launch, with Novo Nordisk contributing ₹45 crore and holding a 76% market share. The gap between the two therapies is narrowing, with further competition expected from Orforglipron.